PolyPid Ltd. (PYPD)
NASDAQ: PYPD · IEX Real-Time Price · USD
4.000
-0.250 (-5.88%)
At close: Jul 2, 2024, 3:59 PM
3.980
-0.020 (-0.50%)
After-hours: Jul 2, 2024, 5:16 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $6.61 million as of July 2, 2024. Its market cap has decreased by -8.14% in one year.
Market Cap
6.61M
Enterprise Value
12.78M
1-Year Change
-8.14%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $312.00M to $6.61M, a decrease of -97.88%. That is a compound annual growth rate of -61.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 7.00M | 11.11% |
| Dec 29, 2023 | 6.30M | -53.68% |
| Dec 30, 2022 | 13.60M | -87.37% |
| Dec 31, 2021 | 107.70M | -33.76% |
| Dec 31, 2020 | 162.60M | -47.88% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XWELL | 7.36M |
| NeuroMetrix | 7.32M |
| Chromocell Therapeutics | 7.21M |
| PAVmed | 7.21M |
| Pulmatrix | 7.16M |
| Kineta | 6.78M |
| Shuttle Pharmaceuticals Holdings | 6.71M |
| ASLAN Pharmaceuticals | 6.52M |